On 12 July 2023, EUCOPE’s HERA Steering Group released its White Paper “EU-wide Stockpiling: Better Preparedness for Cross-Border Health Threats.” Stockpiling of critical biomedical countermeasures is crucial for an effective EU preparedness against priority cross-border health threats with a potentially large health and societal impact…. read more
EUCOPE’S Sounds of Science Podcast – Episode 16 Rare Reflections: Impact of the OMP revision on rare disease companies in Europe On 26 April 2023, the European Commission published its long awaited proposal revising the foundational pharmaceutical legislation, including the Orphan Medicinal Products (OMP) Regulation…. read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of six (6) new members at its quarterly Members Meeting on June 21st, 2023 following Board approval. The new members joining EUCOPE network are Azafaros, Deciphera Pharmaceuticals, Dyne Therapeutics, HemaNext, MediWound and Rocket Pharmaceuticals. During… read more
EUCOPE, along with Exact Sciences, Guardant Health, Illumina, MSD and Novartis, launch the European Coalition for Access to Comprehensive Genomic Profiling (ECGP) The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) along with Exact Sciences, Guardant Health, Illumina, MSD and Novartis, launch the European Coalition for Access… read more
On 30 May, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs hosted the inaugural episode of its Life Science Lectures webinar series, “Attaching conditionalities to incentives: the right path to improve access?” The episode delved into the incentive system outlined in the EU Pharmaceutical Package,… read more
In October 2022, EUCOPE joined a large group of European stakeholders to welcome the European Commission’s proposal on the European Health Data Space (EHDS), and to highlight common recommendations. We share the view that health data are precious and renewable resources that can power decision-making… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In May, we spoke with Gerwin Winter, Senior Vice President – Head of Europe at BeiGene. Gerwin Winter joined BeiGene… read more
On Friday, 5 May, the WHO Director General declared an end to the Public Health Emergency of International Concern (PHEIC) for the disease caused by the coronavirus SARS-CoV-2. COVID-19 was declared a PHEIC on 30 January 2020. For more than three years, the pandemic wreaked… read more
On 4 May 2023, EUCOPE was announced as a member of the Health Technology Assessment (HTA) Stakeholder Network. The Network has been established to facilitate contributions by a wide range of stakeholders to policy development related to HTAs in the European Union (EU). Since its… read more
EUCOPE joined an industry coalition to warn of the potential conflicts between the Data Act and the GDPR, emphasising the importance of ensuring a fair playing field. The letter, sent to several Members of the European Parliament, the Swedish Presidency, and Commissioner Mr. Breton, warns of… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View